SEEBACHER, Nicole A., Mária KRCHNIAKOVÁ, Alexandra E. STACY, Jan ŠKODA and Patric J. JANSSON. Tumour Microenvironment Stress Promotes the Development of Drug Resistance. Antioxidants. Basel: MDPI, 2021, vol. 10, No 11, p. 1801-1832. ISSN 2076-3921. Available from: https://dx.doi.org/10.3390/antiox10111801.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Tumour Microenvironment Stress Promotes the Development of Drug Resistance
Authors SEEBACHER, Nicole A., Mária KRCHNIAKOVÁ (703 Slovakia, belonging to the institution), Alexandra E. STACY, Jan ŠKODA (203 Czech Republic, belonging to the institution) and Patric J. JANSSON.
Edition Antioxidants, Basel, MDPI, 2021, 2076-3921.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 10601 Cell biology
Country of publisher Switzerland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 7.675
RIV identification code RIV/00216224:14310/21:00119405
Organization unit Faculty of Science
Doi http://dx.doi.org/10.3390/antiox10111801
UT WoS 000724516000001
Keywords in English tumour microenvironmental stress; drug resistance; reactive oxygen species; cancer stem cells
Tags rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Marie Šípková, DiS., učo 437722. Changed: 9/12/2021 14:41.
Abstract
Multi-drug resistance (MDR) is a leading cause of cancer-related death, and it continues to be a major barrier to cancer treatment. The tumour microenvironment (TME) has proven to play an essential role in not only cancer progression and metastasis, but also the development of resistance to chemotherapy. Despite the significant advances in the efficacy of anti-cancer therapies, the development of drug resistance remains a major impediment to therapeutic success. This review highlights the interplay between various factors within the TME that collectively initiate or propagate MDR. The key TME-mediated mechanisms of MDR regulation that will be discussed herein include (1) altered metabolic processing and the reactive oxygen species (ROS)-hypoxia inducible factor (HIF) axis; (2) changes in stromal cells; (3) increased cancer cell survival via autophagy and failure of apoptosis; (4) altered drug delivery, uptake, or efflux and (5) the induction of a cancer stem cell (CSC) phenotype. The review also discusses thought-provoking ideas that may assist in overcoming the TME-induced MDR. We conclude that stressors from the TME and exposure to chemotherapeutic agents are strongly linked to the development of MDR in cancer cells. Therefore, there remains a vast area for potential research to further elicit the interplay between factors existing both within and outside the TME. Elucidating the mechanisms within this network is essential for developing new therapeutic strategies that are less prone to failure due to the development of resistance in cancer cells.
Links
GJ20-00987Y, research and development projectName: Mitochondriální dynamika a autofagie: Chybějící článek mezi dediferenciací a vznikem rezistence u solidních nádorů dětského věku
Investor: Czech Science Foundation
PrintDisplayed: 6/10/2024 11:39